SYNAGEVA BIOPHARMA CORP Insider Trading for October 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SYNAGEVA BIOPHARMA CORP for October 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | M | 23.00 | 7,854 | 180,642 | 7,292 | |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | M | 1.70 | 15,050 | 25,585 | 23,164 | |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | M | 23.00 | 1,000 | 23,000 | 15,146 | |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | M | 1.70 | 1,500 | 2,550 | 38,214 | |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 80.11 | 22,904 | 1,834,839 | 0 | 22.9 K to 0 (-100.00 %) |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Buy | M | 23.00 | 7,854 | 180,642 | 22,904 | 15.1 K to 22.9 K (+52.19 %) |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Buy | M | 1.70 | 15,050 | 25,585 | 15,050 | 0 to 15.1 K |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 80.00 | 1,000 | 80,000 | 0 | 1,000 to 0 (-100.00 %) |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | S | 80.00 | 1,500 | 120,000 | 1,000 | 2.5 K to 1,000 (-60.00 %) |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Buy | M | 23.00 | 1,000 | 23,000 | 2,500 | 1.5 K to 2.5 K (+66.67 %) |
| Oct 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Buy | M | 1.70 | 1,500 | 2,550 | 1,500 | 0 to 1.5 K |